Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

CAR-T, TCR, and Beyond: A Rapidly Evolving Revolution in Cancer Cellular Immunotherapeutics

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
CAR-T: A brief historical perspective
Joseph McGuirk
University of Kansas Medical Center, Westwood, KS, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
CAR-T cells in the clinic: Strategies to enhance efficacy and reduce toxicity
Saad J Kenderian
Mayo Clinic, Rochester, MN, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Boutique to global regulatory approval: Constantly enhancing and improving engineered T cells
Bruce Levine
University Of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
Lessons learned from comparing CD28 and 4-1BB-based CD19 CARs
Michel Sadelain
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
The future of CAR T: Allogeneic approach
Ewelina Morawa
CRISPR Therapeutics, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5